This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
GlaxoSmithKline and Pfizer to combine Consumer Health Businesses in 68%/32% JV; £10bn sales, global leader in OTC, targets £1bn divestments, £500m annual savings by 2022; Within 3 yrs, plans to separate JV via demerger, UK listing; GSK div policy unchanged.
Glencore: Katanga Mining enters into settlement agreement with Ontario Securities Commission; Katanga to pay C$30m (US$22.5 m) as part of settlement.
Barclays fined $15m by New York State Department of Financial Services in connection with efforts to uncover whistleblower.
Shire: UK Index Russell will issue further notice today (after the close) about Shire’s replacement within UK 100 on 24 Dec.
UK Index Bookmakers (GVC, William Hill, Paddy Power) could be sensitive to UK government formally enacting £2 FOBT stake limit. As per GVC/Ladbrokes merger, GVC no longer required to pay Ladbrokes shareholders any Contingent Value Rights (est. at £700m).
Virgin Atlantic says still considering potential offer for Flybe, discussions ongoing.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ROYAL DUTCH SHELL B | RDSB | -3.2% | -2.3% | -3.6% |
| WOOD GROUP | WG/ | -8.9% | -5.5% | -9.3% |
| RANDGOLD RESOURCES | RRS | -0.8% | -0.6% | -3.6% |
| ANGLO AMERICAN | AAL | 1.1% | 1.9% | -0.5% |
| INTERCONTINENTAL HOTELS | IHG | -1.0% | 0.6% | -1.5% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research